Anti-Mullerian hormone and endometrial cancer: a multi-cohort study
<p><b>Background:</b> The Mullerian ducts are the embryological precursors of the female reproductive tract, including the uterus; anti-Mullerian hormone (AMH) has a key role in the regulation of foetal sexual differentiation. Anti-Mullerian hormone inhibits endometrial tumour gr...
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
Cancer Research UK
2017
|
| _version_ | 1826275338413408256 |
|---|---|
| author | Fortner, RT Schock, H Jung, S Allen, NE Arslan, AA Brinton, LA Egleston, BL Falk, RT Gunter, MJ Helzlsouer, KJ Idahl, A Johnson, TS Kaaks, R Krogh, V Lundin, E Merritt, MA Navarro, C Onland-Moret, NC Palli, D Shu, XO Sluss, PM Staats, PN Trichopoulou, A Weiderpass, E Zeleniuch-Jacquotte, A Zheng, W Dorgan, JF |
| author_facet | Fortner, RT Schock, H Jung, S Allen, NE Arslan, AA Brinton, LA Egleston, BL Falk, RT Gunter, MJ Helzlsouer, KJ Idahl, A Johnson, TS Kaaks, R Krogh, V Lundin, E Merritt, MA Navarro, C Onland-Moret, NC Palli, D Shu, XO Sluss, PM Staats, PN Trichopoulou, A Weiderpass, E Zeleniuch-Jacquotte, A Zheng, W Dorgan, JF |
| author_sort | Fortner, RT |
| collection | OXFORD |
| description | <p><b>Background:</b> The Mullerian ducts are the embryological precursors of the female reproductive tract, including the uterus; anti-Mullerian hormone (AMH) has a key role in the regulation of foetal sexual differentiation. Anti-Mullerian hormone inhibits endometrial tumour growth in experimental models by stimulating apoptosis and cell cycle arrest. To date, there are no prospective epidemiologic data on circulating AMH and endometrial cancer risk. </p><p><b>Methods:</b> We investigated this association among women premenopausal at blood collection in a multicohort study including participants from eight studies located in the United States, Europe, and China. We identified 329 endometrial cancer cases and 339 matched controls. Anti-Mullerian hormone concentrations in blood were quantified using an enzyme-linked immunosorbent assay. Conditional logistic regression was used to estimate odds ratios (ORs) and 95% confidence intervals (CI) across tertiles and for a doubling of AMH concentrations (OR<sub>log2</sub>). Subgroup analyses were performed by ages at blood donation and diagnosis, oral contraceptive use, and tumour characteristics. </p><p><b>Results:</b> Anti-Mullerian hormone was not associated with the risk of endometrial cancer overall (OR<sub>log2</sub>: 1.07 (0.99–1.17)), or with any of the examined subgroups. </p><p><b>Conclusions:</b> Although experimental models implicate AMH in endometrial cancer growth inhibition, our findings do not support a role for circulating AMH in the aetiology of endometrial cancer.</p> |
| first_indexed | 2024-03-06T22:57:12Z |
| format | Journal article |
| id | oxford-uuid:60d42b62-9d21-4a5a-8237-8c073b3abd0e |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-06T22:57:12Z |
| publishDate | 2017 |
| publisher | Cancer Research UK |
| record_format | dspace |
| spelling | oxford-uuid:60d42b62-9d21-4a5a-8237-8c073b3abd0e2022-03-26T17:55:49ZAnti-Mullerian hormone and endometrial cancer: a multi-cohort studyJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:60d42b62-9d21-4a5a-8237-8c073b3abd0eEnglishSymplectic Elements at OxfordCancer Research UK2017Fortner, RTSchock, HJung, SAllen, NEArslan, AABrinton, LAEgleston, BLFalk, RTGunter, MJHelzlsouer, KJIdahl, AJohnson, TSKaaks, RKrogh, VLundin, EMerritt, MANavarro, COnland-Moret, NCPalli, DShu, XOSluss, PMStaats, PNTrichopoulou, AWeiderpass, EZeleniuch-Jacquotte, AZheng, WDorgan, JF <p><b>Background:</b> The Mullerian ducts are the embryological precursors of the female reproductive tract, including the uterus; anti-Mullerian hormone (AMH) has a key role in the regulation of foetal sexual differentiation. Anti-Mullerian hormone inhibits endometrial tumour growth in experimental models by stimulating apoptosis and cell cycle arrest. To date, there are no prospective epidemiologic data on circulating AMH and endometrial cancer risk. </p><p><b>Methods:</b> We investigated this association among women premenopausal at blood collection in a multicohort study including participants from eight studies located in the United States, Europe, and China. We identified 329 endometrial cancer cases and 339 matched controls. Anti-Mullerian hormone concentrations in blood were quantified using an enzyme-linked immunosorbent assay. Conditional logistic regression was used to estimate odds ratios (ORs) and 95% confidence intervals (CI) across tertiles and for a doubling of AMH concentrations (OR<sub>log2</sub>). Subgroup analyses were performed by ages at blood donation and diagnosis, oral contraceptive use, and tumour characteristics. </p><p><b>Results:</b> Anti-Mullerian hormone was not associated with the risk of endometrial cancer overall (OR<sub>log2</sub>: 1.07 (0.99–1.17)), or with any of the examined subgroups. </p><p><b>Conclusions:</b> Although experimental models implicate AMH in endometrial cancer growth inhibition, our findings do not support a role for circulating AMH in the aetiology of endometrial cancer.</p> |
| spellingShingle | Fortner, RT Schock, H Jung, S Allen, NE Arslan, AA Brinton, LA Egleston, BL Falk, RT Gunter, MJ Helzlsouer, KJ Idahl, A Johnson, TS Kaaks, R Krogh, V Lundin, E Merritt, MA Navarro, C Onland-Moret, NC Palli, D Shu, XO Sluss, PM Staats, PN Trichopoulou, A Weiderpass, E Zeleniuch-Jacquotte, A Zheng, W Dorgan, JF Anti-Mullerian hormone and endometrial cancer: a multi-cohort study |
| title | Anti-Mullerian hormone and endometrial cancer: a multi-cohort study |
| title_full | Anti-Mullerian hormone and endometrial cancer: a multi-cohort study |
| title_fullStr | Anti-Mullerian hormone and endometrial cancer: a multi-cohort study |
| title_full_unstemmed | Anti-Mullerian hormone and endometrial cancer: a multi-cohort study |
| title_short | Anti-Mullerian hormone and endometrial cancer: a multi-cohort study |
| title_sort | anti mullerian hormone and endometrial cancer a multi cohort study |
| work_keys_str_mv | AT fortnerrt antimullerianhormoneandendometrialcanceramulticohortstudy AT schockh antimullerianhormoneandendometrialcanceramulticohortstudy AT jungs antimullerianhormoneandendometrialcanceramulticohortstudy AT allenne antimullerianhormoneandendometrialcanceramulticohortstudy AT arslanaa antimullerianhormoneandendometrialcanceramulticohortstudy AT brintonla antimullerianhormoneandendometrialcanceramulticohortstudy AT eglestonbl antimullerianhormoneandendometrialcanceramulticohortstudy AT falkrt antimullerianhormoneandendometrialcanceramulticohortstudy AT guntermj antimullerianhormoneandendometrialcanceramulticohortstudy AT helzlsouerkj antimullerianhormoneandendometrialcanceramulticohortstudy AT idahla antimullerianhormoneandendometrialcanceramulticohortstudy AT johnsonts antimullerianhormoneandendometrialcanceramulticohortstudy AT kaaksr antimullerianhormoneandendometrialcanceramulticohortstudy AT kroghv antimullerianhormoneandendometrialcanceramulticohortstudy AT lundine antimullerianhormoneandendometrialcanceramulticohortstudy AT merrittma antimullerianhormoneandendometrialcanceramulticohortstudy AT navarroc antimullerianhormoneandendometrialcanceramulticohortstudy AT onlandmoretnc antimullerianhormoneandendometrialcanceramulticohortstudy AT pallid antimullerianhormoneandendometrialcanceramulticohortstudy AT shuxo antimullerianhormoneandendometrialcanceramulticohortstudy AT slusspm antimullerianhormoneandendometrialcanceramulticohortstudy AT staatspn antimullerianhormoneandendometrialcanceramulticohortstudy AT trichopouloua antimullerianhormoneandendometrialcanceramulticohortstudy AT weiderpasse antimullerianhormoneandendometrialcanceramulticohortstudy AT zeleniuchjacquottea antimullerianhormoneandendometrialcanceramulticohortstudy AT zhengw antimullerianhormoneandendometrialcanceramulticohortstudy AT dorganjf antimullerianhormoneandendometrialcanceramulticohortstudy |